Brief: Sesen Bio Says FDA Granted Co's Request For A Type C Meeting

Carisma Therapeutics

12/01/2022 14:14

Jan 12 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO - ON JAN 7, FDA GRANTED CO'S REQUEST FOR A TYPE
C
MEETING REGARDING BLA FOR VICINEUM FOR TREATMENT OF
BCG-UNRESPONSIVE NMIBC
    * SESEN BIO INC - TYPE C MEETING HAS BEEN SCHEDULED FOR
MARCH 28,
2022

Source text for Eikon:  ID: 
Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))